B6;129P2-Prmt2tm1Yah/Orl
Status | Available to order |
EMMA ID | EM:04462 |
International strain name | B6;129P2-Prmt2tm1Yah/Orl |
Alternative name | Prmt2<3HP> |
Strain type | Targeted Mutant Strains : Other targeted |
Allele/Transgene symbol | Prmt2tm1Yah |
Gene/Transgene symbol | Prmt2 |
Information from provider
Provider | Yann Herault |
Provider affiliation | CNRS IEM UMR 6218 |
Genetic information | Insertion by homologous recombination of targeting vector containing loxP site in the locus of Prmt2 (Hrmt1l1) gene (MMU10). |
Phenotypic information | Strain containing a loxP site on the Prmt2 (Hrmt1l1) gene. |
Breeding history | maintained on C57BL/6 background |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Disease and phenotype information
MGI phenotypes (gene matching)
Literature references
- Modeling the monosomy for the telomeric part of human chromosome 21 reveals haploinsufficient genes modulating the inflammatory and airway responses.;Besson Vanessa, Brault Véronique, Duchon Arnaud, Togbe Dieudonné, Bizot Jean-Charles, Quesniaux Valérie F J, Ryffel Bernard, Hérault Yann, ;2007;Human molecular genetics;16;2040-52; 17591625
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).